Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Viracta Therapeutics Inc
Swot
Viracta Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Viracta Therapeutics Inc has 9 Strengths, 10 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(9)
Weakness
(10)
Opportunity
(0)
Threats
(3)
Others
(0)
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Stock gained more than 20% in one month
Stock with Low PE (PE < = 10)
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Declining profits every quarter for the past 2 quarters
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter
Stocks rising sharply on very low month volumes
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
